Sarah Read

2.7k total citations · 1 hit paper
10 papers, 1.2k citations indexed

About

Sarah Read is a scholar working on Infectious Diseases, Virology and Cognitive Neuroscience. According to data from OpenAlex, Sarah Read has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Virology and 2 papers in Cognitive Neuroscience. Recurrent topics in Sarah Read's work include HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). Sarah Read is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). Sarah Read collaborates with scholars based in United States, Sweden and Canada. Sarah Read's co-authors include Marisa Carrasco, Sam Ling, Jeffrey M. Jacobson, Mary F. Kearney, Joseph J. Eron, Ellen S. Chan, Michael M. Lederman, John W. Mellors, Ronald J. Bosch and David M. Margolis and has published in prestigious journals such as Journal of Clinical Oncology, Nature Neuroscience and Clinical Infectious Diseases.

In The Last Decade

Sarah Read

10 papers receiving 1.2k citations

Hit Papers

Attention alters appearance 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Read United States 8 663 395 348 165 102 10 1.2k
Sho K. Sugawara Japan 19 388 0.6× 141 0.4× 79 0.2× 115 0.7× 45 0.4× 39 879
Christine Huang United States 6 454 0.7× 131 0.3× 72 0.2× 188 1.1× 45 0.4× 6 955
Witaya Sungkarat Thailand 11 152 0.2× 233 0.6× 92 0.3× 115 0.7× 160 1.6× 34 705
Stephen M. Carpenter United States 18 166 0.3× 195 0.5× 630 1.8× 44 0.3× 315 3.1× 33 1.4k
Lachlan Gray Australia 25 113 0.2× 1.2k 3.0× 662 1.9× 11 0.1× 215 2.1× 50 1.6k
Hayley Crawford United Kingdom 20 377 0.6× 1.1k 2.7× 418 1.2× 24 0.1× 153 1.5× 56 1.7k
Zheng Hu China 16 313 0.5× 63 0.2× 135 0.4× 13 0.1× 62 0.6× 38 627
Katherine A. Loveland United States 7 283 0.4× 56 0.1× 37 0.1× 32 0.2× 23 0.2× 10 435
Elisabetta Bulgheroni Italy 10 83 0.1× 100 0.3× 100 0.3× 133 0.8× 22 0.2× 19 718
Rachel Corsini Canada 10 184 0.3× 96 0.2× 104 0.3× 72 0.4× 250 2.5× 22 833

Countries citing papers authored by Sarah Read

Since Specialization
Citations

This map shows the geographic impact of Sarah Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Read more than expected).

Fields of papers citing papers by Sarah Read

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Read. The network helps show where Sarah Read may publish in the future.

Co-authorship network of co-authors of Sarah Read

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Read. A scholar is included among the top collaborators of Sarah Read based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Read. Sarah Read is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Benson, Constance A., Janet W. Andersen, Bernard Macatangay, et al.. (2018). Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus–Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy. Clinical Infectious Diseases. 67(11). 1712–1719. 21 indexed citations
2.
Jacobson, Jeffrey M., Steven E. Bosinger, Minhee Kang, et al.. (2016). The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. AIDS Research and Human Retroviruses. 32(7). 636–647. 28 indexed citations
3.
Zheng, Lu, Ronald J. Bosch, Ellen S. Chan, et al.. (2012). Predictors of Residual Viraemia in Patients on Long-Term Suppressive Antiretroviral Therapy. Antiviral Therapy. 18(1). 39–43. 22 indexed citations
4.
Gandhi, Rajesh T., Robert W. Coombs, Ellen S. Chan, et al.. (2011). No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(3). 229–235. 89 indexed citations
5.
Plaeger, Susan, et al.. (2011). Immune Activation in the Pathogenesis of Treated Chronic HIV Disease: A Workshop Summary. AIDS Research and Human Retroviruses. 28(5). 469–477. 52 indexed citations
7.
Gandhi, Rajesh T., Lu Zheng, Ronald J. Bosch, et al.. (2010). The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial. PLoS Medicine. 7(8). e1000321–e1000321. 242 indexed citations
8.
Carrasco, Marisa, Sam Ling, & Sarah Read. (2004). Attention alters appearance. Nature Neuroscience. 7(3). 308–313. 713 indexed citations breakdown →
9.
Carrasco, M., et al.. (2004). Attention alters appearance in early vision: Contrast sensitivity, spatial resolution, and color saturation. Journal of Vision. 4(8). 67–67. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026